[144] Cameco Corporation SEC Filing
Cameco Corporation (CCJ) notice: an individual intends to sell 500 common shares on the NYSE through Solium Financial on 09/10/2025 for an aggregate market value of $39,735. The shares were acquired from long‑term incentive vesting in 2018–2019 (129, 184, and 187 shares on specific vesting dates) with cash payment at acquisition. The filer reports no securities sold in the past three months and affirms they are not aware of any undisclosed material adverse information about the issuer. This form is a Rule 144 notice of proposed sale and documents the planned transaction and acquisition history.
- None.
- None.
Insights
TL;DR: Insider intends to sell a very small block of shares; transaction appears routine and non‑material.
The filing documents a proposed sale of 500 Cameco common shares with an aggregate market value of $39,735, to be executed through Solium Financial on the NYSE. Acquisition records show the shares resulted from vested long‑term incentive awards in 2018–2019 and were paid in cash at vesting. There were no other sales in the prior three months. From a market‑impact perspective, the size of the proposed sale is negligible relative to the 435,387,448 shares outstanding reported here, suggesting limited valuation impact. The notice also contains the standard attestation regarding absence of undisclosed material adverse information.
TL;DR: Form 144 is a compliance disclosure for an insider sale; documentation appears complete for Rule 144 purposes.
The form lists the broker, number of shares, aggregate value, planned sale date, and detailed acquisition history, which are key elements required under Rule 144. The filer states no material nonpublic information is known and discloses that no related sales occurred in the last three months. For governance review, the filing meets the basic transparency standards for an insider sale notice and records that the shares stem from vested LTI awards rather than a gift or transfer.